课题基金 / 基金详情

Increasing CRC Screening in Health Plan Members

Increasing CRC Screening in Health Plan Members
增加健康计划成员的结直肠癌筛查
批准号:
7256940
负责人:
Karen Glanz
金额:
$57.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2009-08-31

项目摘要

项目成果

Karen Glanz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Colorectal cancer is the second most common cause of cancer death in the United States. Early detection and intervention can significantly reduce morbidity and mortality from colorectal cancer (CRC), and current guidelines recommend that asymptomatic adults overage 50 periodically obtain screening by one of several modalities (FOBT, sigmoidoscopy,colonoscopy,or double contrast barium enema). However, CRC screening remains substantially underutilized in the U.S., and more than half of all adults do not adhere to these recommendations. Because key predictors of CRC screening utilization include a physician recommendation and having health insurance, and given the availability of evidence-based strategies for increasing screening uptake, it is important to conduct effectiveness studies in health plan member populations. Our research team proposes to conduct participatory research with a major health insurer, in order to test the transferability of community based behavioral interventions that can increase provision of colorectal cancer screening. We will conduct a cluster-randomized trial in health practices in Georgia and North Carolina, to test the effectiveness of a videotape-based decision aid and academic detailing for increasing adherence to CRC screening guidelines. 30 large group practices will be recruited and randomized to receive usual care (routine reminders) or a combined videotape decision aid and academic detailing intervention. In each practice, 30 patients between the ages of 52 and 75, without current CRC screening history, will be enrolled into the study. The intervention will continue for up to 2 years for still-unscreened participants. The main outcome will be provision (or receipt) of an evidence-based modality of CRC screening according to the US Preventive Services Task Force Guidelines (FOBT, flexible sigmoidoscopy, colonoscopy, or double contrast barium enema). The research team has already begun a participatory research process with key leaders in Quality Improvement and the Medical Economics Units at Aetna, one of the nation's largest health insurers. Unique features of the proposed study include its potential to establish systems to increase screening uptake that will help fulfill HEDIS requirements; improving our understanding of how screening promotion interventions work in both White and Black populations; and forging collaborative relationships between public health and health care researchers, and the affected communities of health plans and health care providers.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
A Hybrid Type 1 Effectiveness-Implementation Study of Social Incentives Strategies to Increase Physical Activity
  • 批准号:
    10199038
  • 项目类别:
  • 资助金额:
    $78.97万
  • 财政年份:
    2020
  • 负责人:
    Karen Glanz
  • 依托单位:
A Hybrid Type 1 Effectiveness-Implementation Study of Social Incentives Strategies to Increase Physical Activity
  • 批准号:
    10647727
  • 项目类别:
  • 资助金额:
    $75.02万
  • 财政年份:
    2020
  • 负责人:
    Karen Glanz
  • 依托单位:
A Hybrid Type 1 Effectiveness-Implementation Study of Social Incentives Strategies to Increase Physical Activity
  • 批准号:
    10452570
  • 项目类别:
  • 资助金额:
    $77.34万
  • 财政年份:
    2020
  • 负责人:
    Karen Glanz
  • 依托单位:
PRoject Implementation, Dissemination, and Evaluation (PRIDE) Core
  • 批准号:
    8820833
  • 项目类别:
  • 资助金额:
    $1.23万
  • 财政年份:
    2015
  • 负责人:
    Karen Glanz
  • 依托单位:
国内基金
海外基金
固本消积颗粒通过TIMP-1抑制SDF-1/CXCR3依赖性中性粒细胞募集重塑CRC肝前转移生态位的临床及基础研究
从巨噬细胞极化调控炎症及肿瘤微环境探究UC-CRC的发病机制及中医药干预研究
  • 批准号:
    2025JJ90101
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    余炼
  • 依托单位:
从GPR81/HIF-1 α驱动的MDSC代谢重塑联 合DESI-MSI/AFM策略探讨紫草多糖抑制 CRC进程的药效物质结构和作用机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    邵萌
  • 依托单位:
piRNA-823通过调节结直肠癌细胞代谢重编程促进CRC细胞增殖的 机制研究